USANA Health Sciences (USNA) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities
Net earnings	78.16M
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	9.93M
Loss on sale of property and equipment	55K
Equity-based compensation expense	13.96M
Excess tax benefits from equity-based payment arrangements	0
Deferred income taxes	-2.25M
Inventory valuation
Changes in operating assets and liabilities:
Inventories	-7.92M
Prepaid expenses and other assets	-12.18M
Accounts payable	597K
Other liabilities	1.39M
Total adjustments
Net cash provided by operating activities
Cash flows from investing activities
Proceeds from sale of property and equipment	3K
Purchases of property and equipment	-26.05M
Net cash used in investing activities
Cash flows from financing activities
Proceeds from equity awards exercised
Excess tax benefits from equity-based payment arrangements	0
Repurchase of common stock	-64.61M
Payments on line of credit	-72.5M
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents	-1.3M
Net increase in cash and cash equivalents	-8.67M
Cash and cash equivalents, beginning of period	143.21M
Cash and cash equivalents, end of period	134.54M
Supplemental disclosures of cash flow information
Interest	317K
Income taxes	41.11M

Entities mentioned with USNA